These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 10968905

  • 1. Use of the dilute Russell viper venom time (dRVVT): its importance and pitfalls.
    Triplett DA.
    J Autoimmun; 2000 Sep; 15(2):173-8. PubMed ID: 10968905
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M, Dlott J, Norbis F, Ruggeri L, Cler L, Triplett DA, Barbui T.
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [Abstract] [Full Text] [Related]

  • 4. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM, Rodrigues CA, Noguti MA, Matos MF, da Silveira RC, Ribeiro AA, Lourenço DM.
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [Abstract] [Full Text] [Related]

  • 5. Lupus anticoagulants: diagnostic dilemma and clinical challenge.
    Triplett DA.
    Clin Lab Sci; 1997 Jul; 10(4):223-8. PubMed ID: 10169622
    [Abstract] [Full Text] [Related]

  • 6. The effect of phospholipid on the detection of lupus anticoagulants by the dilute Russell viper venom time.
    Brandt JT, Triplett DA.
    Arch Pathol Lab Med; 1989 Dec; 113(12):1376-8. PubMed ID: 2511818
    [Abstract] [Full Text] [Related]

  • 7. Warfarin does not interfere with lupus anticoagulant detection by dilute Russell's viper venom time.
    Olteanu H, Downes KA, Patel J, Praprotnik D, Sarode R.
    Clin Lab; 2009 Dec; 55(3-4):138-42. PubMed ID: 19462936
    [Abstract] [Full Text] [Related]

  • 8. Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients.
    Moore GW, Culhane AP, Maloney JC, Archer RA, Breen KA, Hunt BJ.
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):477-80. PubMed ID: 26656903
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneity of Russell's viper venom affects the sensitivity of the dilute Russell's viper venom time to lupus anticoagulants.
    Moore GW, Savidge GF.
    Blood Coagul Fibrinolysis; 2004 Apr; 15(3):279-82. PubMed ID: 15060428
    [Abstract] [Full Text] [Related]

  • 10. Protean clinical presentation of antiphospholipid-protein antibodies (APA).
    Triplett DA.
    Thromb Haemost; 1995 Jul; 74(1):329-37. PubMed ID: 8578480
    [Abstract] [Full Text] [Related]

  • 11. Comparison between a one-point dilute phospholipid APTT and the dilute Russell viper venom time for verification of lupus anticoagulants.
    Alving BM, Barr CF, Johansen LE, Tang DB.
    Thromb Haemost; 1992 Jun 01; 67(6):672-8. PubMed ID: 1509408
    [Abstract] [Full Text] [Related]

  • 12. [Usefulness of silica clotting time for detection of lupus anticoagulants].
    Lee HR, Kim JE, Ha SH, Kim HK, Park S, Cho HI.
    Korean J Lab Med; 2009 Dec 01; 29(6):497-504. PubMed ID: 20046079
    [Abstract] [Full Text] [Related]

  • 13. [Clinical diagnosis of thrombosis and blood coagulation tests].
    Watanabe K.
    Rinsho Byori; 1998 Mar 01; 46(3):235-44. PubMed ID: 9564763
    [Abstract] [Full Text] [Related]

  • 14. Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity.
    Moore GW, Peyrafitte M, Dunois C, Amiral J.
    Lupus; 2018 Jan 01; 27(1):95-104. PubMed ID: 28549386
    [Abstract] [Full Text] [Related]

  • 15. Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids.
    Pengo V, Balestrieri G, Tincani A, Spatola L, Biasiolo A, Brocco T.
    Thromb Haemost; 1997 Jan 01; 77(1):123-6. PubMed ID: 9031461
    [Abstract] [Full Text] [Related]

  • 16. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification.
    Triplett DA, Barna LK, Unger GA.
    Thromb Haemost; 1993 Nov 15; 70(5):787-93. PubMed ID: 8128436
    [Abstract] [Full Text] [Related]

  • 17. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
    Tripodi A, Chantarangkul V, Clerici M, Mannucci PM.
    Thromb Haemost; 2002 Oct 15; 88(4):583-6. PubMed ID: 12362227
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anti-factor VIII inhibitors and lupus anticoagulants in haemophilia A patients.
    Blanco AN, Cardozo MA, Candela M, Santarelli MT, Pérez Bianco R, Lazzari MA.
    Thromb Haemost; 1997 Apr 15; 77(4):656-9. PubMed ID: 9134638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.